Accessibility Information

Users of assistive technologies such as screen readers should use the following link to activate Accessibility Mode before continuing: Learn more and Activate accessibility mode.

Targeted Clinical Trials to Reduce the Risk of Antimicrobial Resistance

Solicitation Number: BAA-NIAID-DMID-NIHAI2008025
Agency: Department of Health and Human Services
Office: National Institutes of Health
Location: National Institute of Allergy and Infectious Diseases
  • Print
:
BAA-NIAID-DMID-NIHAI2008025
:
Award Notice
:
August 3, 2009
:
HHSN272200900022C-HHSN272200900023C
:
HHSN272200900022C: Base Period: $1,463,044; Options: $12,349,817
:
Children's Hospital of Philadelphia and Duke University
:
Children's Hospital of Philadelphia
34th Street Civic Center Boulevard
Philadelphia, PA 19104-4318

Duke University
2200 West Main Street, Suite 300
Durham, NC 27705-4677
,
United States
:
Added: Aug 03, 2009 5:50 pm

These contracts will provide for the design and conduct of Phase III and/or Phase IV clinical trials to develop and test different therapeutic approaches/regimens that will reduce overexposure to antimicrobial drugs, thereby decreasing the likelihood of antimicrobial drug resistance and preserving the effectiveness of existing antimicrobials.

:
Office of Acquisitions
6700 B Rockledge Room 3214 MSC7612
Bethesda, Maryland 20892-7612
:
Timni Mahase,
Contract Specialist
Phone: 301-496-0612
Fax: N/A
:
Michael Finn,
Contract Specialist
Phone: 301-496-3699
Fax: 301-402-0972